More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Artemic eu sale approval and clinical trial update

Sep 15, 2021 at 11:58 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Sep 15, 2021 at 11:58 PM EDT

On 6ix: 6ix.com/news/artemic-eu-sale-approval-and-clinical-trial-update

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • Uk import permit granted for cannepilSep 14, 2021
  • Cimetra import approval granted for indiaSep 3, 2021
  • Cimetra patent submitted to european ip officeMay 18, 2021

Earlier from Argent Biopharma

  • Uk import permit granted for cannepilSep 13, 2021
  • Cimetra import approval granted for indiaSep 3, 2021
  • Mgc pharma executes US$24M US supply agreementAug 26, 2021
  • Patent application lodged for novel drug delivery systemJul 15, 2021
  • 1St patient recruited into cimetra phase 3 clinical trialJul 12, 2021

Later from Argent Biopharma

  • First order received under US supply agreementSep 29, 2021
  • Amc inc. places US$3M cimetra purchase orderOct 6, 2021
  • Response to ASX Query LetterOct 15, 2021
  • Cimetra dose finding study approvalNov 1, 2021
  • Malta cimetra production facility updateNov 2, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer